Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Research & Development: 2022-2025

Historic Research & Development for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $45.5 million.

  • Gossamer Bio's Research & Development rose 30.50% to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.3 million, marking a year-over-year increase of 21.86%. This contributed to the annual value of $138.5 million for FY2024, which is 2.35% up from last year.
  • Latest data reveals that Gossamer Bio reported Research & Development of $45.5 million as of Q3 2025, which was up 9.54% from $41.6 million recorded in Q2 2025.
  • Over the past 5 years, Gossamer Bio's Research & Development peaked at $45.5 million during Q3 2025, and registered a low of $30.0 million during Q4 2023.
  • In the last 3 years, Gossamer Bio's Research & Development had a median value of $36.1 million in 2024 and averaged $36.3 million.
  • Its Research & Development has fluctuated over the past 5 years, first fell by 29.90% in 2023, then soared by 30.50% in 2025.
  • Over the past 4 years, Gossamer Bio's Research & Development (Quarterly) stood at $41.5 million in 2022, then fell by 27.80% to $30.0 million in 2023, then grew by 20.49% to $36.1 million in 2024, then soared by 30.50% to $45.5 million in 2025.
  • Its last three reported values are $45.5 million in Q3 2025, $41.6 million for Q2 2025, and $38.0 million during Q1 2025.